Kerry Stokes’ Media Executives and Their Interest in Orthocell
What could explain Seven West Media’s sharp focus on the relatively small ASX-listed medtech company Orthocell? The attention is surprising, given that most people have never heard of it.
About Orthocell
Orthocell is a Perth-based medical technology firm specializing in cell regeneration therapies. It originated from the University of Western Australia in 2007 and has grown steadily since then.
Market Performance
The company’s market capitalization hovers near $300 million, with its stock rising approximately 80 percent over the past year. Despite that, Orthocell remains one of several small medtech players trading on the ASX.
Follow the topics, people, and companies that matter to you.
Author’s summary: Seven West Media’s fascination with Orthocell highlights how even niche biotech firms can capture mainstream interest through strong market performance and innovative research.